Analysis of the Efficacy of Low-Dose Betaloc Combined with Amiodarone in Treating Ventricular Arrhythmia

Abstract

Objective: To explore and analyze the clinical effect of low-dose Betaloc combined with amiodarone in treating ventricular arrhythmia. Methods: 70 patients with ventricular arrhythmia who were admitted to the Department of Cardiology of our hospital between August 2022 and August 2023 were selected as research subjects. They were divided into two groups using the coin-tossing method: the combination group (n = 35) and the reference group (n = 35). The combination group was treated with low-dose Betaloc and amiodarone, and the control group was treated with low-dose Betaloc alone. The treatment efficacy, cardiac function indicators, and related tested indicators of the two groups were compared. Results: The total efficacy of the treatment received by the combination group was much higher than that of the control group (P < 0.05). Besides, after treatment, the cardiac function indicators such as left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV), and cardiac index (CI) of the patients in the combination group were significantly better than those of the reference group (P < 0.05). Furthermore, the high-sensitivity C-reactive protein (Hs-CRP), N-terminal prohormone of brain natriuretic peptide (NT-proBNP), adiponectin (APN), and other related test indicators of the patients in the combination group were significantly better than those of the reference group (P < 0.05). Conclusion: Low-dose Betaloc combined with amiodarone has a noticeable effect in treating ventricular arrhythmia and deserves to be widely promoted.